Cargando…

Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer

BACKGROUND: Tumor-infiltrating lymphocyte (TIL) therapy is a personalized cancer treatment which involves generating ex vivo cultures of tumor-reactive T cells from surgically resected tumors and administering the expanded TILs as a therapeutic infusion. Phase 1 of many TIL production protocols use...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Mitchell W, Abdelhakim, Haitham, Li, Meizhang, Hyter, Stephen, Pessetto, Ziyan, Koestler, Devin C, Pathak, Harsh B, Dunavin, Neil, Godwin, Andrew K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549459/
https://www.ncbi.nlm.nih.gov/pubmed/33037114
http://dx.doi.org/10.1136/jitc-2020-000706
_version_ 1783592796925460480
author Braun, Mitchell W
Abdelhakim, Haitham
Li, Meizhang
Hyter, Stephen
Pessetto, Ziyan
Koestler, Devin C
Pathak, Harsh B
Dunavin, Neil
Godwin, Andrew K
author_facet Braun, Mitchell W
Abdelhakim, Haitham
Li, Meizhang
Hyter, Stephen
Pessetto, Ziyan
Koestler, Devin C
Pathak, Harsh B
Dunavin, Neil
Godwin, Andrew K
author_sort Braun, Mitchell W
collection PubMed
description BACKGROUND: Tumor-infiltrating lymphocyte (TIL) therapy is a personalized cancer treatment which involves generating ex vivo cultures of tumor-reactive T cells from surgically resected tumors and administering the expanded TILs as a therapeutic infusion. Phase 1 of many TIL production protocols use aldesleukin (IL-2) alone to establish TIL cultures (termed “PreREP” (Pre-Rapid Expansion Protocol)); however, this fails to consistently produce TIL cultures from renal cell carcinoma (RCC) in a timely manner. Adding mitogenic stimulation via anti-CD3/anti-CD28 beads along with IL-2 to the fresh tumor digest (FTD) during TIL generation (termed “FTD+ beads”) increases successful TIL culture rates; however, T cells produced by this method may be suboptimal for adoptive transfer. We hypothesize that adherent cell depletion (ACD) before TIL expansion will produce a superior TIL product by removing the immunosuppressive signals originating from adherent tumor and stromal cells. Here we investigate if “panning,” a technique for ACD prior to TIL expansion, will impact the phenotype, functionality and/or clonality of ex vivo expanded RCC TILs. METHODS: Tumor specimens from 55 patients who underwent radical or partial nephrectomy at the University of Kansas Medical Center (KUMC) were used to develop the panning method and an additional 19 specimens were used to validate the protocol. Next-generation sequencing, immunohistochemistry/immunocytochemistry and flow cytometry were used during method development. The phenotype, functionality and clonality of autologous TILs generated in parallel by panning, PreREP, and FTD+ beads were assessed by flow cytometry, in vitro co-culture assays, and TCRB CDR3 sequencing. RESULTS: TIL cultures were successfully generated using the panning protocol from 15/16 clear cell, 0/1 chromophobe, and 0/2 papillary RCC samples. Significantly fewer regulatory (CD4+/CD25+/FOXP3+) (p=0.049, p=0.005), tissue-resident memory (CD8+/CD103+) (p=0.027, p=0.009), PD-1+/TIM-3+ double-positive (p=0.009, p=0.011) and TIGIT+ T cells (p=0.049, p=0.026) are generated by panning relative to PreREP and FTD+ beads respectively. Critically, a subset of TILs generated by panning were able to degranulate and/or produce interferon gamma in response to autologous tumor cells and the average tumor-reactive TIL yield was greatest when using the panning protocol. CONCLUSIONS: Removing immunosuppressive adherent cells within an RCC digest prior to TIL expansion allow for the rapid production of tumor-reactive T cells with optimal characteristics for adoptive transfer.
format Online
Article
Text
id pubmed-7549459
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75494592020-10-19 Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer Braun, Mitchell W Abdelhakim, Haitham Li, Meizhang Hyter, Stephen Pessetto, Ziyan Koestler, Devin C Pathak, Harsh B Dunavin, Neil Godwin, Andrew K J Immunother Cancer Immune Cell Therapies and Immune Cell Engineering BACKGROUND: Tumor-infiltrating lymphocyte (TIL) therapy is a personalized cancer treatment which involves generating ex vivo cultures of tumor-reactive T cells from surgically resected tumors and administering the expanded TILs as a therapeutic infusion. Phase 1 of many TIL production protocols use aldesleukin (IL-2) alone to establish TIL cultures (termed “PreREP” (Pre-Rapid Expansion Protocol)); however, this fails to consistently produce TIL cultures from renal cell carcinoma (RCC) in a timely manner. Adding mitogenic stimulation via anti-CD3/anti-CD28 beads along with IL-2 to the fresh tumor digest (FTD) during TIL generation (termed “FTD+ beads”) increases successful TIL culture rates; however, T cells produced by this method may be suboptimal for adoptive transfer. We hypothesize that adherent cell depletion (ACD) before TIL expansion will produce a superior TIL product by removing the immunosuppressive signals originating from adherent tumor and stromal cells. Here we investigate if “panning,” a technique for ACD prior to TIL expansion, will impact the phenotype, functionality and/or clonality of ex vivo expanded RCC TILs. METHODS: Tumor specimens from 55 patients who underwent radical or partial nephrectomy at the University of Kansas Medical Center (KUMC) were used to develop the panning method and an additional 19 specimens were used to validate the protocol. Next-generation sequencing, immunohistochemistry/immunocytochemistry and flow cytometry were used during method development. The phenotype, functionality and clonality of autologous TILs generated in parallel by panning, PreREP, and FTD+ beads were assessed by flow cytometry, in vitro co-culture assays, and TCRB CDR3 sequencing. RESULTS: TIL cultures were successfully generated using the panning protocol from 15/16 clear cell, 0/1 chromophobe, and 0/2 papillary RCC samples. Significantly fewer regulatory (CD4+/CD25+/FOXP3+) (p=0.049, p=0.005), tissue-resident memory (CD8+/CD103+) (p=0.027, p=0.009), PD-1+/TIM-3+ double-positive (p=0.009, p=0.011) and TIGIT+ T cells (p=0.049, p=0.026) are generated by panning relative to PreREP and FTD+ beads respectively. Critically, a subset of TILs generated by panning were able to degranulate and/or produce interferon gamma in response to autologous tumor cells and the average tumor-reactive TIL yield was greatest when using the panning protocol. CONCLUSIONS: Removing immunosuppressive adherent cells within an RCC digest prior to TIL expansion allow for the rapid production of tumor-reactive T cells with optimal characteristics for adoptive transfer. BMJ Publishing Group 2020-10-09 /pmc/articles/PMC7549459/ /pubmed/33037114 http://dx.doi.org/10.1136/jitc-2020-000706 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Immune Cell Therapies and Immune Cell Engineering
Braun, Mitchell W
Abdelhakim, Haitham
Li, Meizhang
Hyter, Stephen
Pessetto, Ziyan
Koestler, Devin C
Pathak, Harsh B
Dunavin, Neil
Godwin, Andrew K
Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title_full Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title_fullStr Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title_full_unstemmed Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title_short Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer
title_sort adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating t cells with optimal characteristics for adoptive transfer
topic Immune Cell Therapies and Immune Cell Engineering
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549459/
https://www.ncbi.nlm.nih.gov/pubmed/33037114
http://dx.doi.org/10.1136/jitc-2020-000706
work_keys_str_mv AT braunmitchellw adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT abdelhakimhaitham adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT limeizhang adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT hyterstephen adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT pessettoziyan adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT koestlerdevinc adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT pathakharshb adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT dunavinneil adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer
AT godwinandrewk adherentcelldepletionpromotestheexpansionofrenalcellcarcinomainfiltratingtcellswithoptimalcharacteristicsforadoptivetransfer